Isabella M Fabian, Evan S Sinnathamby, Chelsi J Flanagan, Anne Lindberg, Brynne Tynes, Rucha A Kelkar, Giustino Varrassi, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D Kaye
Topical hydroquinone (HQ) has been used for decades to treat disorders of hyperpigmentation such as melasma, post-inflammatory hyperpigmentation, and solar lentigines. Additionally, it has been used as a skin-lightening agent for cosmetic purposes. Multiple studies have shown it to be effective in treating hyperpigmentation, though it is not without side effects. Currently, HQ is not approved for over-the-counter use in the United States. Its use is also banned in other countries, including Japan, Australia, and the European Union...
November 2023: Curēus